Pfizer Inc. has launched the company’s first ever dedicated commercial analytics centre in India called, ‘the Analytics Gateway’. The Analytics Gateway represents a significant milestone in Pfizer’s international commercial strategy and is positioned to be a global capability centre serving all of Pfizer’s international (ex-US)
Abrocitinib is the first-of-its-kind oral advanced systemic treatment for adults with moderate-to-severe atopic dermatitis, to be made available in India. Abrocitinib provides rapid itch relief, sustained control of the disease and improved quality of life. Pfizer has received marketing authorization for abrocitinib in adults
